Pharmacogenetics, Adverse Drug Reactions and Public Health

Publisher： Karger

E-ISSN： 1662-8063|9|1|50-54

ISSN： 1662-4246

Source： Public Health Genomics, Vol.9, Iss.1, 2006-02, pp. : 50-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ethics of Clinical Science in a Public Health Emergency: Drug Discovery at the Bedside

By Edwards Sarah J. L.  

American Journal of Bioethics, Vol. 13, Iss. 9, 2013-09 ,pp. : 3-14

Routledge Ltd

Access to resources Recommend Favorite

Alcohol and Drug Testing of Health Professionals Following Preventable Adverse Events: A Bad Idea

By  

American Journal of Bioethics, Vol. 14, Iss. 12, 2014-12 ,pp. : 25-36

Routledge Ltd

Access to resources Recommend Favorite

Genome-wide association study identifies HLA-A3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

By Ozeki Takeshi   Mushiroda Taisei   Yowang Amara   Takahashi Atsushi   Kubo Michiaki   Shirakata Yuji   Ikezawa Zenro   Iijima Masafumi   Shiohara Tetsuo   Hashimoto Koji   Kamatani Naoyuki   Nakamura Yusuke  

Human Molecular Genetics, Vol. 20, Iss. 5, 2011-03 ,pp. : 1034-1041

Oxford University Press

Access to resources Recommend Favorite

Pharmacogenetics: implications for drug development, patients and society

By McCarthy Alun  

New Genetics & Society, Vol. 19, Iss. 2, 2000-08 ,pp. : 135-143

Routledge Ltd

Access to resources Recommend Favorite

Pharmacogenetics of Parkinson’s Disease – Through Mechanisms of Drug Actions

By  

Current Genomics, Vol. 14, Iss. 8, 2013-12 ,pp. : 568-577

Bentham Science Publishers

Access to resources Recommend Favorite